Insider Buying and Selling - PRLD

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
03/25/2025	03/27/2025	Combs Andrew Chief Chemistry Officer Officer	Buy	100,000 @ $0.69	$69,250.00	480,123	(26.31%)	Direct
03/25/2025	03/27/2025	Vaddi Krishna CEO CEO Director	Buy	675,000 @ $0.69	$467,437.50	1,999,296	(50.97%)	Direct
03/21/2025	03/24/2025	Vaddi Krishna CEO CEO Director	Buy	15,000 @ $0.73	$10,959.00	1,324,296	(1.15%)	Direct
03/20/2025	03/24/2025	Vaddi Krishna CEO CEO Director	Buy	5,416 @ $0.73	$3,950.43	1,309,296	(0.42%)	Direct
03/17/2025	03/18/2025	Vaddi Krishna CEO CEO Director	Buy	9,106 @ $0.75	$6,828.59	1,303,880	(0.70%)	Direct
03/14/2025	03/18/2025	Vaddi Krishna CEO CEO Director	Buy	29,999 @ $0.75	$22,631.25	1,294,774	(2.37%)	Direct
03/13/2025	03/14/2025	Vaddi Krishna CEO CEO Director	Buy	50,000 @ $0.72	$35,820.00	1,264,775	(4.12%)	Direct
03/12/2025	03/14/2025	Vaddi Krishna CEO CEO Director	Buy	47,500 @ $0.71	$33,744.00	1,214,775	(4.07%)	Direct
12/23/2024	12/26/2024	Combs Andrew Chief Chemistry Officer Officer	Buy	60,000 @ $1.37	$82,002.00	377,623	(18.89%)	Direct
12/20/2024	12/26/2024	Combs Andrew Chief Chemistry Officer Officer	Buy	3,075 @ $1.15	$3,536.25	317,623	(0.98%)	Direct
12/19/2024	12/20/2024	Lim Bryant David CLO, Interim CFO, Corp Sec. CFO	Buy	25,000 @ $0.91	$22,637.50	27,400	(1,041.67%)	Direct
12/18/2024	12/20/2024	Vaddi Krishna CEO CEO Director	Buy	100,000 @ $0.93	$93,210.00	1,167,275	(9.37%)	Direct

Prelude Therapeutics Inc - PRLD